An NIH grant does not move from idea to award on a single, linear timeline the way a private gift or a one-off contract might. It moves through a repeating annual system: three standard receipt dates, a two-level peer review process, a funding decision, and then — if funded — a further cycle of annual progress reporting that repeats until the project period ends and the recipient either seeks a competing renewal or closes the award out. This guide walks through that full annual cycle in order, from submission to renewal. For the underlying mechanism types (R-series, K-series, cooperative agreements) and how NIH funding announcements work, see CASRAI’s companion NIH Grants: An Overview guide — this page is the process/timeline view, not the mechanism-and-terminology view, and deliberately does not repeat that content.
The three standard annual receipt cycles
Most investigator-initiated NIH applications submitted under a standard Parent Announcement follow one of three standard due dates per year, sometimes referred to informally as Cycle I, II, and III. The exact day varies slightly by activity code and by whether the application is new or a resubmission/renewal/revision — see CASRAI’s NIH Standard Due Dates entry for the full table across activity-code groups. For the most common R-series research grant (R01), the standard pattern is:
| Cycle | New applications due | Resubmission / renewal / revision due |
|---|---|---|
| Cycle I | February 5 | March 5 |
| Cycle II | June 5 | July 5 |
| Cycle III | October 5 | November 5 |
These are the general R01 dates; other activity codes (R03, R21, R33, K-series, and others) shift by several days within the same three annual windows — always confirm the exact date against the specific Notice of Funding Opportunity (NOFO) rather than assuming the general pattern applies, since Requests for Applications (RFAs) and many program-specific PARs set their own, different receipt dates entirely.
Step 1: Submission, receipt, and assignment
Applications are prepared and submitted electronically — typically via ASSIST or a system-to-system solution routed through Grants.gov — and require an active institutional eRA Commons registration for the Signing Official/Authorized Organizational Representative before submission is possible. Once NIH’s Center for Scientific Review (CSR) receives an application, its Division of Receipt and Referral assigns it to both a funding Institute or Center (IC) and a specific study section, based on the application’s scientific content matched against each study section’s published referral guidelines. Applicants may request a specific study section or IC using the PHS Assignment Request Form, but final assignment rests with CSR scientific staff. See CASRAI’s NIH Study Section entry for how chartered study sections differ from Special Emphasis Panels and how the referral process works in more detail.
Step 2: Scientific merit review (study section)
This is the first of NIH’s two required review levels. A study section — formally a Scientific Review Group — evaluates and scores the application for scientific and technical merit, typically at a meeting held a few months after the receipt date. Reviewers assign individual scores; the group’s overall priority score and percentile ranking, along with a written summary statement documenting the discussion, are the output of this stage. Most study sections are convened by CSR; RFAs and some program-specific competitions instead use a Special Emphasis Panel (SEP) convened directly by the issuing IC. This is a distinct process from an institution’s own Scientific Review Committee (SRC), which reviews an already-funded or funding-pending clinical trial protocol’s design at the site where it will run — see CASRAI’s Scientific Review Committee entry for that separate, institutional-level process, and the Pink Team, Red Team, Gold Team guide for how institutions run their own internal proposal review before submission, which is separate again from NIH’s post-submission peer review described here.
Step 3: Second-level review (advisory council)
Only applications that clear study section move to the second review level: the funding IC’s advisory council or board performs a programmatic and relevance review, using the study section’s summary statement and score. Advisory councils typically meet three times a year, timed to follow each of the three standard receipt cycles by a further interval — this second review level is one of the main reasons a funded R01 can take the better part of a year, sometimes longer, from submission to award. Council review considers scientific merit alongside programmatic priorities, portfolio balance, and available IC funding, so a well-scored application is not an automatic award; council concurrence and an IC funding decision are still required.
Step 4: Just-in-Time (JIT)
For applications being seriously considered for funding — generally those scoring within a fundable range after council review — NIH requests additional information electronically through the Just-in-Time (JIT) feature of eRA Commons, rather than requiring it with the original application. JIT commonly includes: updated Other Support information for all Senior/Key Personnel (in NIH’s required format), an updated budget if requested, evidence of any required human subjects or vertebrate animal approvals not already on file, and — for awards subject to the NIH Data Management and Sharing (DMS) Policy — any needed revision to the DMS Plan. NIH’s own guidance directs applicants to submit JIT information at least 60 days before the proposed project start date, or sooner if the IC requests it. Being asked for JIT information is a strong signal an award is likely, but it is not itself a funding commitment — only the Notice of Award is.
Step 5: Funding decision and Notice of Award
Once JIT information is in and the IC makes a final funding decision, NIH issues the Notice of Award (NoA) — the official, legally binding document notifying the recipient institution that a grant has been made. Funds cannot be drawn down before the NoA is issued; the application itself was only a request, not a commitment. Each NoA covers one budget period (typically 12 months) within the project’s full, multi-year project period, and carries an award number combining NIH’s assigned serial number with a two-digit support-year suffix that increments with each subsequent budget-period NoA. The document is organized into an Award Data section (budget breakdown, F&A costs, anticipated future-year commitments), a Payment Information section, and Terms and Conditions sections covering both NIH’s standard terms and any award-specific special conditions. Only a Grants Management Specialist or Grants Officer — not the program officer — has authority to sign an NoA, obligate funds, or modify its terms.
Step 6: Post-award — annual progress reporting
An NIH award’s project period is funded incrementally, one budget period at a time, contingent on continued appropriations and satisfactory progress — a multi-year project period is not a guarantee that every subsequent year’s funds will be released automatically. For each non-competing continuation year, the recipient documents progress through the Research Performance Progress Report (RPPR), submitted electronically through eRA Commons. See CASRAI’s NIH RPPR guide for the report’s full structure and deadlines, and the NIH RPPR worked example for a filled-in walkthrough. If a project genuinely needs more time to complete its approved scope within the funds already awarded, a no-cost extension is the applicable mechanism — it extends the period of performance without adding funds, rather than restarting the review cycle described above.
Step 7: End of project period — competing renewal or new application
When a project period’s final budget period approaches its end, the recipient faces a choice that re-enters the cycle described above rather than exiting it. A Type 2 competing renewal requests support beyond the current award’s project period; it must be fully developed and peer-reviewed as though it were a new application, competing for funding on the same terms as any Type 1 (new) application, through the same study-section-then-council review sequence. Not every mechanism supports a Type 2 renewal — R01 does, but R21, for example, has no renewal mechanism, so a project funded on an R21 must seek an entirely new award if the work continues. See CASRAI’s Type 1 vs. Type 2 Grant comparison for the fuller distinction, including how the application-type digit appears in an NIH grant number. If a project is ending without a renewal, closeout requirements — including final RPPR submission and, where applicable, invention reporting — apply; see CASRAI’s federal grant closeout guide for that process.
Putting the full cycle together
For a standard-cycle R01 application with no complications, the stages above run roughly in this order: submission at one of the three standard due dates, CSR assignment, a study section meeting several months later, the next available advisory council round, JIT information collection if the score is fundable, and — if funded — a Notice of Award. Research offices commonly describe the full standard-cycle timeline, from receipt date to Notice of Award, as running roughly nine to eleven months, though this is a general planning estimate rather than an NIH-guaranteed figure: it varies by Institute, by council meeting schedule, by appropriations timing, and by whether an application is funded on its first submission or requires a resubmission (which adds a full additional cycle). RFAs and program-specific PARs frequently compress or restructure this general timeline — always check the specific NOFO’s own review and award timeline rather than assuming the standard-cycle pattern applies.
Frequently asked questions
How long does the full NIH grant cycle take from submission to award?
For a standard-cycle application with no resubmission, research offices commonly estimate roughly nine to eleven months from the standard due date to Notice of Award, driven mainly by the gap between the receipt date and the study section meeting, and then the further gap to the next advisory council round. RFAs and program-specific PARs often run on a different, sometimes faster, timeline — check the specific NOFO.
What happens if my application isn’t funded on the first submission?
A resubmission is possible, submitted one month after the relevant standard due date (for example, March 5 following a February 5 new-application deadline) and reviewed through the same study-section-then-council sequence in the next cycle. A resubmission is a substantively revised application addressing the prior summary statement’s critiques, not a resubmission of the identical document.
Is getting a Just-in-Time request a guarantee of funding?
No. A JIT request signals NIH is seriously considering the application for funding and needs updated information to finalize a decision, but only the Notice of Award itself is a binding funding commitment.
Does the annual cycle apply to every NIH funding mechanism?
The three standard due dates and two-level review process described here apply to most investigator-initiated grants submitted under a standing Program Announcement. RFAs typically set their own single receipt date and use a dedicated review panel rather than a standard study section; some mechanisms (for example, most administrative supplements) skip competitive peer review entirely. Always confirm against the specific NOFO.
What is the difference between a project period and a budget period in this cycle?
The project period is the full multi-year span NIH approved for the science; the budget period is the current increment — usually 12 months — actually funded by a given Notice of Award. Later years of a multi-year project period are funded incrementally through annual progress reporting (RPPR), not released all at once at the initial award.
Related CASRAI resources
This guide focuses on the calendar and process flow of an NIH award. For the mechanism types and funding-announcement terminology underneath it, see NIH Grants: An Overview. For the pre-award and post-award vocabulary this cycle depends on, see the Grants Management & Research Funding cluster hub. Other directly relevant CASRAI pages: NIH Standard Due Dates, NIH Study Section, NIH Grants Policy Statement, NIH RPPR, No-Cost Extension (NCE), Type 1 vs. Type 2 Grant, and NIH Grant Terminations.
